GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Short Interest

Microbix Biosystems (TSX:MBX) Short Interest


View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Microbix Biosystems's Short Interest

For the Biotechnology subindustry, Microbix Biosystems's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microbix Biosystems's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Short Interest distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Short Interest falls into.


Microbix Biosystems (TSX:MBX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Short Interest
Comparable Companies
TSX:HBP TSX:BCT TSX:MSCL XCNQ:DTC XCNQ:GLAB TSXV:NRX TSXV:TTI TSXV:GSD NEOE:BMND TSXV:COV OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
MBXBF:USA
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Website
https://www.microbix.com
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.
Executives
James Stuart Currie Senior Officer

Microbix Biosystems (TSX:MBX) Headlines

No Headlines